Muyiwa Arike Elesho, LCSW in Bladensburg, MD - Medicare Provider

Muyiwa Arike Elesho, LCSW is a medicare enrolled "Social Worker - Clinical" provider in Bladensburg, Maryland. Her current practice location is 4432 Blue Heron Way, Bladensburg, Maryland. You can reach out to her office (for appointments etc.) via phone at (347) 446-8629.

Muyiwa Arike Elesho is licensed to practice in Virginia (license number 0904012486) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1558959924.

Contact Information

	Muyiwa Arike Elesho, LCSW
	4432 Blue Heron Way, Bladensburg, MD 20710-1899
	(347) 446-8629
	Not Available

Healthcare Provider's Profile

Full Name	Muyiwa Arike Elesho
Gender	Female
Speciality
Experience	Years
Location	4432 Blue Heron Way, Bladensburg, Maryland
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Muyiwa Arike Elesho attended and graduated from in

NPI Data:

NPI Number: 1558959924
Provider Enumeration Date: 01/01/2021
Last Update Date: 01/01/2021

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Muyiwa Arike Elesho such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558959924	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	0904012486 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Muyiwa Arike Elesho is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Muyiwa Arike Elesho, LCSW 4432 Blue Heron Way, Bladensburg, MD 20710-1899 Ph: (347) 446-8629	Muyiwa Arike Elesho, LCSW 4432 Blue Heron Way, Bladensburg, MD 20710-1899 Ph: (347) 446-8629

News Archive

Advances in leadless pacing: an interview with Dr. Reddy

Pacemakers have been around for a very long time, they're great devices, critical for many people who have slow heartbeats. While they're very effective, they have some issues. There are two main aspects relating to these issues.

Accreditation Canada releases 2010 Report on ROPs to improve quality and patient safety in health services

In celebration of Canadian Patient Safety Week, Accreditation Canada has released its 2010 Report on Required Organizational Practices, which presents accreditation results from Canadian health organizations that underwent accreditation in 2009. The report focuses on national results for Accreditation Canada's Required Organizational Practices (ROPs), which are evidence-based practices that minimize risk and contribute to improving quality and patient safety in health services.

Genetic testing can be used to distinguish between ischemic and nonischemic forms of heart failure

Researchers at Johns Hopkins have shown that genetic testing can be effectively used to distinguish between heart failure patients who suffer from ischemic or nonischemic forms of the disease.

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).

Human neural stem cells to treat Pelizaeus-Merzbacher Disease

StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.

Social Worker in Bladensburg, MD

Fatmata Ndoye, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4233 58th Ave Apt 5, Bladensburg, MD 20710 Phone: 240-960-4963
Ms. Angelique Alisia Brathwaite, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5800 Annapolis Rd Apt 801, Bladensburg, MD 20710 Phone: 410-504-2776

Muyiwa Arike Elesho, LCSW - Medicare Clinical Social Worker in Bladensburg, MD